Remaining logical when the herd panics is always a good idea when investing, but it’s especially important during pandemic-induced selloffs. Read More
Analyst Articles
A surge of mergers and acquisitions is transforming the marijuana industry, bringing together blue-chip financiers with pot pioneers. Read More
Despite the coronavirus and its variants, stocks continue to climb a wall of worry, as investors overcome a succession of fears and obstacles. Read More
December is an opportune time to conduct important annual financial work. One of our top experts reveals his regimen. Read More
We’re witnessing greater market volatility amid the latest COVID mutation. As 2022 looms, here are the risks and rewards for investors. Read More
The restaurant sector has taken a beating since the emergence of the Omicron variant of COVID-19, and here is how you can profit from it. Read More
When mainstream influencers aren't creating false gods, they're sowing panic. Amid COVID-generated volatility, it pays to be contrarian. Read More
The “next big thing” in the booming psychotropics industry? Tourist packages predicated on LSD, magic mushrooms, and other psychedelic drugs. Read More
Despite renewed fears about COVID, the U.S. economy continues to beat growth projections for jobs and manufacturing. Read More
The market's recent swoon begs the question: are chip-maker stocks good buys now? These criteria can help you decide. Read More